title: Compounding pharmacies: a viable option, or merely a liability?
authors.affiliation: Department of PM&R, University of North Carolina School of Medicine, NC; Orthopaedic Specialists of the Carolinas, PA, Winston Salem, NC(∗).
authors.forename: David
authors.initials: D
authors.lastname: O'Brien
authors.forename: Isaac
authors.initials: I
authors.lastname: Cohen
authors.forename: David J
authors.initials: DJ
authors.lastname: Kennedy
mesh_terms: D001623:Betamethasone / Q000737:chemistry*; D002626:Chemistry, Pharmaceutical; D004196:Disease Outbreaks; D004339:Drug Compounding / Q000592:standards*; D004340:Drug Contamination; D006801:Humans; D016365:Liability, Legal; D008581:Meningitis / Q000453:epidemiology; D010594:Pharmacies / Q000592:standards*; D010818:Practice Patterns, Physicians' / Q000706:statistics & numerical data*; D011787:Quality of Health Care; D014481:United States / Q000453:epidemiology
chemical_list: D001623:Betamethasone